echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Wave Eye Scouting 2020 Sip Club . . . How do Chinese pharmaceutical companies transform from imitation to creation?

    Wave Eye Scouting 2020 Sip Club . . . How do Chinese pharmaceutical companies transform from imitation to creation?

    • Last Update: 2020-09-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On August 12, the Health Industry Capital Summit kicked off at the Boao Forum for Asia Hotel in Hainan, with the opening of the 2020 China Health Industry Ecological Conference.
    the summit was organized by Zhongkang Information, CITIC Securities and Guosheng Securities.
    held a six-day conference on the theme of "Day by Day - A New Era of Health Management for the Full Life Cycle".
    As the conference's in-depth cooperative media, Sina Pharmaceuticals (micro-signal: sinayiyao) full special report, special topics, micro-blogs, WeChat synchronous pictures, for the attention of the guests of this industry event to bring a visual feast in person, we will be the first time to package the conference dry goods hard goods presented to the audience.
    During the round-table discussion on the theme of "Commercialization and Future Competitive Situation of Innovative Pharmaceuticals" chaired by Junshi Bio Assistant General Manager Yu Wenbing, Hengrui Pharmaceuticals Deputy General Manager Tao Weikang, Baiji Shenzhou China General Manager and President Wu Xiaobin and China Biopharmaceutical Executive Director and Vice President Xie Wei and Fuhong Hanxuan Co-Founder and CEO Liu Shigao conducted in-depth exchanges on the innovation path of Chinese pharmaceutical companies.
    the following is the round-table dialogue session guest point of view: Moderator: Whether Chinese pharmaceutical companies copy to create how to choose the future of innovation? Xie: Innovation is actually an eternal issue, I think our definition of innovation can not be too limited, as well as the production process innovation is also very important, management innovation.
    Tao Weikang: I think that the innovation and imitation of various companies are complementary, there is no innovation there is imitation.
    Innovation is a multi-dimensional thing, there are molecules, targets, new mechanisms of innovation, as well as new combinations of innovation, new molecular forms of innovation, this I think is innovation, the key to your final success or whether it has no value in the market, clinically there is no value, if it is valuable, then I think the market will be recognized and reasonable return.
    In addition, do imitation words each company has its own mechanism, Hengrui is doing, we call the new special difficulty, the new is to strive for very new, special is to have characteristics of things, such as dosage form, to have their own characteristics.
    is difficult in itself, and technology is relatively complex.
    In the final analysis, there is innovation in the imitation process, dosage form innovation is also an innovation, can not say which is good, but according to their own company's situation, and finally depends on whether there is a position in the market.
    : I think China's great completion can allow generic drugs.
    we have to focus on tradition, but also much better than original, so we win."
    : Companies do innovative drugs, and economics says the economy is limited, whether it's the efficiency of research and development or the efficiency of production.
    because to deal with the 4 plus 7, if looking for other companies to increase the cost of research and development, so we are more to do their own, reduce costs, sales network is the same.
    , efficiency and cost are important in addition to efficacy.
    On the one hand, and we develop innovative drugs, on the other hand, we set up three platforms, we sifted several chemicals, our pulmonary fibrosis drugs are also in cooperation, we and if the relatively controlled research and development company is also doing brain infarction.
    , on the one hand to do with peers, on the other hand to improve their ability.
    note: There are deletions in the original text.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.